Compare Abeona Therapeutics Inc (ABEO) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Matson Inc — how do they compare? Abeona Therapeutics Inc trades at $7.34 (market cap $421.19M), while Matson Inc trades at $211.9 (market cap $6.11B). The key difference: Matson Inc is far larger — about 14.5× Abeona Therapeutics Inc's market cap, and Matson Inc pays a 0.74% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | MATX | |
|---|---|---|
Market Cap | $421.19M | $6.11B |
Sector | Health | Technology |
52-Week High | $7.45 | $223.55 |
52-Week Low | $4.17 | $88.05 |
Enterprise Value | $276.10M | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
